Turning Point Brands (TPB) stock fell 15.5% this week following reports that the FDA is hesitant to approve new nicotine pouch types due to safety concerns, particularly regarding use among children. The company's fast-growing nicotine pouch brand Fre, which grew 266% year-over-year and represents 34% of revenues, is now facing regulatory headwinds. The stock has declined 50% from its highs.

Turning Point Brands stock plummeted over 14% after Reuters reported that FDA scientists have significant concerns about nicotine pouches and oral nicotine products, citing risks to new users and children. The regulatory hesitation could delay or block approval of Turning Point's pending products including new Stoker's tobacco lines and its Fre nicotine pouch product line, making growth difficult for the company.

Turning Point Brands (TPB) stock plummeted 33% this week after missing Q4 earnings expectations and issuing weak 2026 guidance. Despite rapid 266% year-over-year growth in its nicotine pouch business, the company is investing heavily in marketing and distribution, causing adjusted earnings to drop significantly from $119 million annualized to $24-27 million expected in Q1. However, analysts suggest the stock may now be attractively valued at a P/S ratio of 3.7 for a fast-growing company in the nicotine sector.

The oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, driven by consumer shift toward tobacco-free and functional beverage formats. Major players including Celsius Holdings, British American Tobacco, Turning Point Brands, and Keurig Dr Pepper are expanding their portfolios with innovative energy and oral pouch products to capture growing demand for portable, controlled-dose stimulant delivery systems.

Turning Point Brands (TPB) shares fell over 16.5% on Monday despite beating Q4 2025 earnings expectations with net sales up 29.2% YoY to $121 million. While Modern Oral segment sales surged 266% YoY and the company raised its quarterly dividend, declines in legacy Zig-Zag brand sales weighed on investor sentiment. The company projects FY26 Modern Oral revenue of $180-190 million.

Altria Group (MO), a Dividend King with 56 consecutive years of dividend growth, offers a 6.3% forward dividend yield and has delivered 18% annualized returns over five years, outperforming the S&P 500. However, the company lags in smoke-free product innovation compared to competitor Philip Morris International, with 88% of revenue still from smokeable products. Despite past failures in smoke-free ventures, modest success in future smokeless products could significantly boost valuations, making it an attractive buy-and-hold opportunity for dividend investors.

Stoker's, a leading American smokeless tobacco manufacturer, announced the launch of Stoker's Proud, a new value-focused sub-brand featuring 100% American-grown tobacco. The new line includes two styles in classic 1.2-ounce cans and is designed to serve price-conscious consumers while maintaining the company's quality standards and heritage.

First Sabrepoint Capital Management sold 90,000 shares of Walker & Dunlop for $6.39 million, reducing its stake from 3.18% to 0.70% of assets. Despite the stock declining 30% over the past year, Walker & Dunlop's underlying business shows strength with 16% revenue growth, 34% increase in transaction volume, and a 4% rise in servicing portfolio. However, credit metrics warrant monitoring as defaulted loans are trending higher year-over-year.

David Edward Glazek, executive chairman of Turning Point Brands, sold 30,000 shares worth $3.31 million on December 19 following an options exercise. Despite the substantial 19.1% reduction in his direct holdings, the sale appears liquidity-driven rather than a sign of weakening fundamentals, as the company recently delivered strong Q3 results with 31.2% revenue growth and raised full-year guidance.

4D Advisors initiated a significant $9.34 million position in U.S. Physical Therapy (USPH), making it their third-largest holding. Despite the stock being down 18.75% in the past year, the investment suggests a bullish outlook on the company's potential in the fragmented rehab market.

Divisadero Street Capital Management acquired a new $55.85 million position in Stride, representing 2.44% of its assets. Despite a recent significant stock drop due to platform upgrade issues, the author sees potential opportunity in the online education company trading at a low earnings multiple.

President Trump achieved a historic Gaza Peace Deal, his 8th major peace agreement. The administration addressed domestic issues like designating Antifa as a terrorist organization, approved the Ambler Road project, and made economic progress with dropping oil prices and launching Trump Rx pharmaceutical platform.